Like Facebook, Sandberg connects instantly

Sheryl Sandberg, COO of Facebook is in India.

Sandberg sat down among the journalists instead of her designated seat.
She had a bad throat, she said, and wanted to be close. Close enough for selfies with
the reporters present.
Some of them had met her earlier and mentioned those meetings. Sandberg, naturally,
would have forgotten but instantly warmed up to the memories. Like Facebook, she
connected instantly.
She is the author of Lean In: Women, Work, And the Will to Lead.
Sandberg is scheduled to meet Prime Minister Narendra Modi during her stay in
India.
The (Facebook) post with the picture of Prime Minister Modi seeking his mothers
blessings is incredible and my personal favourite,
She said. I am a mother too. This really touches my heart.
Modi is the most followed politician after Barack Obama on Facebook, with 18
million fans.
Sikka to mint Rs 30 cr a year at Infy - New CEO will
also get $2 million in stock options
In line with expectations, Vishal Sikka, chief executive officer (CEO)-designate of
city based Infosys, is set to become the highest-paid executive in the Indian
information technology (IT) services space.
As experts had estimated, Sikkas salary structure has a large variable component,
keeping in mind the fact that he has been brought in to arrest the companys weak
business performance.
He will be paid an annual base salary of $900,000 and an annual variable pay of $4.18
million, besides being eligible to receive annual stock options valued at $2 million.
Honda vrooming past Bajaj - From the rural areas
Honda's economy bikes retailed under 'Dream'
brand contributed 35-40% of its total motorcycle
sales
After attaining supremacy and retaining it in the scooter segment, Honda is now
inching towards closing the gap between Bajaj Auto and itself in the motorcycle
segment.
Riding on motorcycle launches over the past two years, Honda Motorcycle and
Scooter India (HMSI) has narrowed the gap with Bajaj Auto, which gave up the
scooter segment five years ago, to focus exclusively on motorcycles.
In May 2013, domestic volumes of Bajaj Auto stood at 212,129 units, 126,263 units
more than that of Honda. This gap, however, shrunk dramatically to 23,563 units this
May, according to data by the Society of Indian Automobile Manufacturers. The gap
was more than 157,000 units in May 2011.
While Honda's new launches, especially in the economy segment, have helped the
Japanese brand, weakening demand hit Bajaj the most.
In May, for instance, Bajaj Auto sales dropped 17 per cent to 176,277 units, against
212,129 units in May 2013. This is when the motorcycle sector posted growth of 12
per cent.
In the rural segment, Honda's economy bikes, retailed under 'Dream' brand,
contributes 35-40 per cent to its total motorcycle sales.
To up its ante, HMSI will launch its most affordable 110cc bike in a month's time,
which will again be under the Dream-series brand.
Bajaj Auto sells motorcycles under its flagship brands Pulsar, Discover, Platina and
Avenger. Discover, a brand developed to cater to the economy segment, contributes
46% while Pulsar contributes 30% of overall domestic volumes of the company.
Further, HMSI dethroned Bajaj last financial year to emerge as the second biggest
producer of two-wheelers in India.
HMSI clocked total sales (domestic + export) of 3,722,049 units last year while Bajaj
Auto sold 3,422,403 units in the same year. Hero MotoCorp remains in the lead with
total sales of 6,245,960 units.
Reliance Media Works & PFL merge global film
services biz
Anil Ambani's Reliance MediaWorks (RMW) and global media and entertainment
industry services provider Prime Focus Ltd (PFL) have merged their global film and
media services businesses.
RMW and Prime Focus promoters Naresh and Namit Malhotra will each infuse fresh
equity capital of Rs 120 crore into Prime Focus at Rs 52 a share through a preferential
allotment, raising the equity capital by Rs 240 crore.
This will be used to fund the recent merger of Double Negative, a European visual
effects house, with PFL subsidiary Prime Focus World. After the preferential
allotment and the business combination as above, the fully-diluted shareholding of
PFL promoters will be 33.5 per cent, while RMW's will be 30.2 per cent.
As part of the transaction, the India and overseas operations of RMW's film and
media services business will be combined with PFL through a slump sale. This
includes a total of 1 million sq ft of facilities including studio facilities in Film City,
Mumbai, 30 per cent stake in renowned Hollywood visual effects (VFX) company
Digital Domain, widely acclaimed for its award winning work for Titanic and The
Curious Case of Benjamin Button; and 100 per cent ownership of Los Angeles-based
digital film restoration firm Lowry Digital, an Oscar winner for scientific and
technical achievement in 2012. Combining the two, RMW's investment in the deal is
valued just shy of Rs 500 crore.
The promoters of PFL and RMW simultaneously announced a mandatory open offer
to the extent of 26 per cent of the fully-diluted share capital of PFL, at Rs 52 a share.
The combination of RMW-PFL and Double Negative, led by Matt Holben and Alex
Hope, results in an integrated media services group with over 5,500 people present
across 20 locations offering visual effects, stereo 3D conversion, animation and
cloud-based digital media solutions that transcend the film, advertising and television
industries.
For Prime Focus, the deal is a means of achieving scale, which will increase its
bandwidth across core services and in the long-term, help it achieve better margins on
the operating level.
Sun Pharma hits record; Ranbaxy touches 20-month
high - In past one week, Sun Pharma and Ranbaxy
has rallied over 12% each on the National Stock
Exchange.
In past one week, both these stocks have outperformed the market by gaining more
than 12% each after USFDA granted approval to Ranbaxy's subsidiary Ohm
Laboratories to manufacture and sell generic Diovan in the US.
The benchmark CNX Nifty has gained 3% and CNX Pharma sector index by 8%
during the same period.
Analyst at J.P. Morgan in a recent research report said the approval for Diovan
positively for Sun Pharma and Ranbaxy even as the deal is yet to be completed and
approval for generic Nexium (another first to file for Ranbaxy) will be another
catalyst going forward.

Additional Readings
http://www.business-standard.com/article/opinion/a-
question-of-energy-114063001098_1.html
http://www.business-
standard.com/article/opinion/the-47-million-
114070201274_1.html